Publications
Detailed Information
Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Oh, Jung-Min | - |
dc.contributor.author | Kim, Su-Hyeong | - |
dc.contributor.author | Lee, Yun-Il | - |
dc.contributor.author | Seo, Miran | - |
dc.contributor.author | Song, Yong-Sang | - |
dc.contributor.author | Juhnn, Yong-Sung | - |
dc.contributor.author | Kim, Woo-Ho | - |
dc.contributor.author | Kim, So-Young | - |
dc.date.accessioned | 2012-06-26T00:13:45Z | - |
dc.date.available | 2012-06-26T00:13:45Z | - |
dc.date.issued | 2009-01 | - |
dc.identifier.citation | CARCINOGENESIS; Vol.30 1; 141-149 | ko_KR |
dc.identifier.issn | 0143-3334 | - |
dc.identifier.uri | https://hdl.handle.net/10371/77407 | - |
dc.description.abstract | Human papillomavirus (HPV) is the major cause of uterine cervical cancer, but the role of the HPV E5 in carcinogenesis is not clearly understood. Prostaglandins are known to contribute to carcinogenesis of cervical cancer, and we therefore investigated the effect of HPV16 E5 on the expression of prostaglandin E2 (PGE2) receptors and underlying mechanisms. Stable expression of the E5 induced expression of the EP4 subtype of PGE2 receptors in C33A cervical cancer cells, and transfection of E5 small interfering RNA (siRNA) decreased it. EP4 protein expression was increased in human cervical cancer tissues, and EP4 mediated E5-induced increase in anchorage-independent colony formation and vascular endothelial growth factor expression. E5 induced cyclooxygenase-2 (COX-2) expression, and COX-2 increased PGE2 secretion and EP4 expression. The induction of EP4 by PGE2 and E5 was inhibited by an EP4 antagonist, inhibitors of cyclic adenosine monophosphate-dependent protein kinase or phosphatidylinositol 3-kinase, and a cyclic adenosine monophosphate response element (CRE) decoy. E5 increased the luciferase expression controlled by a variant CRE of the EP4 promoter, and it also increased the binding of cyclic adenosine monophosphate response element binding protein (CREB) to oligonucleotides containing this CRE. We conclude that the HPV16 E5 protein induces EP4 receptor protein in cervical cancer cells and that this induction involves epidermal growth factor receptor, COX-2, PGE2, EP2 and EP4, protein kinase A, CREB and CRE. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | OXFORD UNIV PRESS | ko_KR |
dc.title | Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cells | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 오정민 | - |
dc.contributor.AlternativeAuthor | 김수형 | - |
dc.contributor.AlternativeAuthor | 이윤일 | - |
dc.contributor.AlternativeAuthor | 서미란 | - |
dc.contributor.AlternativeAuthor | 김소영 | - |
dc.contributor.AlternativeAuthor | 송용상 | - |
dc.contributor.AlternativeAuthor | 김우호 | - |
dc.contributor.AlternativeAuthor | 전용성 | - |
dc.identifier.doi | 10.1093/carcin/bgn236 | - |
dc.citation.journaltitle | CARCINOGENESIS | - |
dc.description.citedreference | Kim SY, 2008, J BIOL CHEM, V283, P1350, DOI 10.1074/jbc.M702344200 | - |
dc.description.citedreference | Lee HS, 2007, INT J ONCOL, V31, P859 | - |
dc.description.citedreference | Cherukuri DP, 2007, EXP CELL RES, V313, P2969, DOI 10.1016/j.yexcr.2007.06.004 | - |
dc.description.citedreference | Chun KS, 2007, MOL CARCINOGEN, V46, P699, DOI 10.1002/mc.20354 | - |
dc.description.citedreference | Maufort JP, 2007, CANCER RES, V67, P6106, DOI 10.1158/0008-5472.CAN-07-0921 | - |
dc.description.citedreference | Siu YT, 2007, FEBS J, V274, P3224, DOI 10.1111/j.1742-4658.2007.05884.x | - |
dc.description.citedreference | Hawcroft G, 2007, ONCOGENE, V26, P3006, DOI 10.1038/sj.onc.1210113 | - |
dc.description.citedreference | Subbaramaiah K, 2007, CANCER RES, V67, P3976, DOI 10.1158/0008-5472.CAN-06-4273 | - |
dc.description.citedreference | Han SW, 2007, J BIOL CHEM, V282, P7961, DOI 10.1074/jbc.M610308200 | - |
dc.description.citedreference | Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050 | - |
dc.description.citedreference | Fulton AM, 2006, CANCER RES, V66, P9794, DOI 10.1158/0008-5472.CAN-06-2067 | - |
dc.description.citedreference | Ma XR, 2006, CANCER RES, V66, P2923, DOI 10.1158/0008-5472.CAN-05-4348 | - |
dc.description.citedreference | Han SW, 2005, J BIOL CHEM, V280, P33240, DOI 10.1074/jbc.M507617200 | - |
dc.description.citedreference | Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102 | - |
dc.description.citedreference | GENTHERWILLIAMS SM, 2005, CANCER RES, V65, P6534 | - |
dc.description.citedreference | Spinella F, 2004, J BIOL CHEM, V279, P46700, DOI 10.1074/jbc.M408584200 | - |
dc.description.citedreference | Muller R, 2004, J CANCER RES CLIN, V130, P429, DOI 10.1007/s00432-004-0570-y | - |
dc.description.citedreference | Therland KL, 2004, J AM SOC NEPHROL, V15, P1189, DOI 10.1097/01.ASN.0000124673.79934.24 | - |
dc.description.citedreference | Bradbury DA, 2003, J BIOL CHEM, V278, P49954, DOI 10.1074/jbc.M307964200 | - |
dc.description.citedreference | Conkright MD, 2003, MOL CELL, V11, P1101 | - |
dc.description.citedreference | Araki Y, 2003, CANCER RES, V63, P728 | - |
dc.description.citedreference | Fujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200 | - |
dc.description.citedreference | Sales KJ, 2002, CANCER RES, V62, P424 | - |
dc.description.citedreference | Mutoh M, 2002, CANCER RES, V62, P28 | - |
dc.description.citedreference | Faour WH, 2001, J BIOL CHEM, V276, P31720 | - |
dc.description.citedreference | Sales KJ, 2001, J CLIN ENDOCR METAB, V86, P2243 | - |
dc.description.citedreference | Chang JL, 2001, J BIOMED SCI, V8, P206, DOI 10.1159/000054034 | - |
dc.description.citedreference | Venuti A, 1998, VIROLOGY, V248, P1 | - |
dc.description.citedreference | Cavuslu S, 1996, CLIN DIAGN VIROL, V5, P215 | - |
dc.description.citedreference | COLEMAN RA, 1994, PHARMACOL REV, V46, P205 | - |
dc.description.citedreference | ZUR HH, 1994, ANNU REV MICROBIOL, V48, P427 | - |
dc.description.citedreference | AN SZ, 1993, BIOCHEM BIOPH RES CO, V197, P263 | - |
dc.description.citedreference | STRAIGHT SW, 1993, J VIROL, V67, P4521 | - |
dc.description.citedreference | JONES DA, 1993, J BIOL CHEM, V268, P9049 | - |
dc.description.citedreference | PIOMELLI D, 1993, J LIPID MEDIATOR, V6, P433 | - |
dc.description.citedreference | SHERMAN L, 1992, INT J CANCER, V50, P356 | - |
dc.description.citedreference | LEECHANACHAI P, 1992, ONCOGENE, V7, P19 | - |
dc.description.citedreference | TISCHER E, 1991, J BIOL CHEM, V266, P11947 | - |
dc.description.citedreference | FINK JS, 1988, P NATL ACAD SCI USA, V85, P6662 | - |
dc.description.citedreference | BAKER CC, 1987, J VIROL, V61, P962 | - |
dc.description.citedreference | SCHWARZ E, 1985, NATURE, V314, P111 | - |
dc.description.tc | 8 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.